GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tsubota Laboratory Inc (TSE:4890) » Definitions » Float Percentage Of Total Shares Outstanding

Tsubota Laboratory (TSE:4890) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 18, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Tsubota Laboratory Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Tsubota Laboratory's float shares is 0.00 Mil. Tsubota Laboratory's total shares outstanding is 25.58 Mil. Tsubota Laboratory's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Tsubota Laboratory's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Tsubota Laboratory's Institutional Ownership is 0.84%.


Tsubota Laboratory Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Tsubota Laboratory's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/25.58
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tsubota Laboratory (TSE:4890) Business Description

Industry
Traded in Other Exchanges
N/A
Address
34 Shinanomachi, 304 Toshin Shinanomachi-ekimae Building, Shinjuku-ku, Tokyo, JPN, 160-0016
Tsubota Laboratory Inc is engaged in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia.

Tsubota Laboratory (TSE:4890) Headlines

No Headlines